HHGA
JAZZ icon

Halbert Hargrove Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225 Buy
+1
New +$219 ﹤0.01% 638
2025
Q4 		– Sell
-7
Closed -$923 – 564
2025
Q3 		$923 Buy
+7
New +$840 ﹤0.01% 670

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Halbert Hargrove Global Advisors's JAZZ Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1 share worth $225. The stake represents ﹤0.01% of the portfolio and ranks #638 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in JAZZ as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in JAZZ in Q3 2025 and has held it in 2 quarters since. The position peaked at $923 in Q3 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Halbert Hargrove Global Advisors held 1 share of Jazz Pharmaceuticals worth $225 as of Q2 2026.
  • Jazz Pharmaceuticals was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #638 holding.
  • Halbert Hargrove Global Advisors first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Halbert Hargrove Global Advisors's Jazz Pharmaceuticals position peaked at $923 in Q3 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.